Comparing short‐term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®
Sign Up to like & getrecommendations! Published in 2020 at "ESC Heart Failure"
DOI: 10.1002/ehf2.12649
Abstract: Centrifugal continuous flow pumps are currently the state of the art in left ventricular assist device therapy. This study was conducted to compare the results after implantation of the HVAD® and the HeartMate 3®. read more here.
Keywords: heartmate; term outcome; comparing short; hvad ... See more keywords
Gastrointestinal Bleeding After HeartMate II or HVAD Implantation: Incidence, Location, Etiology, and Effect on Survival
Sign Up to like & getrecommendations! Published in 2019 at "ASAIO Journal"
DOI: 10.1097/mat.0000000000000998
Abstract: The number of patients on destination therapy is increasing as long-term survival on continuous-flow left ventricular assist device (CF-LVAD) therapy has improved. Gastrointestinal bleeding (GIB) is a common complication after CF-LVAD implantation, and its risk… read more here.
Keywords: gib; gastrointestinal bleeding; incidence; etiology ... See more keywords
Usefulness of HVAD Waveforms as Diagnostic assistance for Cardiac tamponade.
Sign Up to like & getrecommendations! Published in 2020 at "ASAIO Journal"
DOI: 10.1097/mat.0000000000001303
Abstract: We experienced a 39-year-old male patient who converted paracorporeal left ventricular assist device to HeartWare ventricular assist device (HVAD; Medtronic, Framingham, MA) as bridge-to-transplant indication. On the 10th postoperative day, the HVAD flow waveform presented… read more here.
Keywords: cardiac tamponade; hvad waveforms; usefulness hvad; hvad ... See more keywords
HVAD Usage and Outcomes in the Current Pediatric Ventricular Assist Device Field: An Advanced Cardiac Therapies Improving Outcomes Network (ACTION) Analysis
Sign Up to like & getrecommendations! Published in 2021 at "ASAIO Journal"
DOI: 10.1097/mat.0000000000001373
Abstract: Advanced Cardiac Therapies Improving Outcomes Network (ACTION) is the first pediatric ventricular assist device (VAD) quality improvement network (46 centers). We aimed to describe outcomes with the HeartWare HVAD from ACTION centers. Patients with an… read more here.
Keywords: advanced cardiac; action; therapies improving; network ... See more keywords
First-in-Man Use of a Modified Controller to Resolve HVAD Failure-to-Restart.
Sign Up to like & getrecommendations! Published in 2023 at "ASAIO journal"
DOI: 10.1097/mat.0000000000001911
Abstract: We report a case of Medtronic HeartWare ventricular assist device (HVAD) pump failure-to-restart. Despite HVAD withdrawal from the market in June 2021, up to 4,000 patients remain on HVAD support worldwide, and many are at… read more here.
Keywords: failure restart; controller; first man; man use ... See more keywords
Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices
Sign Up to like & getrecommendations! Published in 2021 at "Circulation"
DOI: 10.1161/circulationaha.121.055716
Abstract: Supplemental Digital Content is available in the text. Background: Ischemic and hemorrhagic cerebrovascular accidents remain common among patients with centrifugal-flow left ventricular assist devices, despite improvements in survival and device longevity. We compared the incidence… read more here.
Keywords: hazard; centrifugal flow; flow left; ventricular assist ... See more keywords
Abstract WP230: Stroke Characteristics and Outcomes in Patients With Current Generation Centrifugal Flow Left Ventricular Assist Devices
Sign Up to like & getrecommendations! Published in 2020 at "Stroke"
DOI: 10.1161/str.51.suppl_1.wp230
Abstract: Introduction: Stroke is a devastating complication of left ventricular assist device (LVAD) therapy and a leading cause of mortality in this group. The newer HeartMate (HVAD, 2012) and HeartMate 3 (HM3, 2017) devices use a… read more here.
Keywords: generation; hm3; centrifugal; hvad ... See more keywords